Brokerages Set electroCore, Inc. (NASDAQ:ECOR) Target Price at $22.00

Shares of electroCore, Inc. (NASDAQ:ECORGet Free Report) have been given an average recommendation of “Hold” by the five analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, two have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $22.00.

Several equities research analysts have weighed in on the company. Zacks Research downgraded electroCore from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Brookline Capital Acquisition upgraded shares of electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th. Wall Street Zen upgraded shares of electroCore from a “sell” rating to a “hold” rating in a report on Saturday, November 8th. Finally, HC Wainwright reduced their price objective on shares of electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a report on Monday, January 26th.

Check Out Our Latest Report on ECOR

Institutional Investors Weigh In On electroCore

Several hedge funds and other institutional investors have recently made changes to their positions in ECOR. Jaffetilchin Investment Partners LLC boosted its holdings in electroCore by 7.4% in the fourth quarter. Jaffetilchin Investment Partners LLC now owns 52,363 shares of the company’s stock valued at $235,000 after purchasing an additional 3,600 shares in the last quarter. Two Sigma Investments LP lifted its position in shares of electroCore by 20.8% during the 3rd quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock worth $122,000 after buying an additional 4,231 shares during the last quarter. International Assets Investment Management LLC boosted its holdings in shares of electroCore by 15.2% in the 4th quarter. International Assets Investment Management LLC now owns 88,720 shares of the company’s stock valued at $398,000 after buying an additional 11,700 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in shares of electroCore in the 4th quarter valued at $82,000. Finally, Jane Street Group LLC raised its stake in electroCore by 114.4% during the 1st quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after acquiring an additional 19,599 shares in the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

electroCore Stock Up 4.7%

Shares of ECOR stock opened at $7.97 on Monday. The firm has a 50 day moving average of $6.20 and a two-hundred day moving average of $5.45. The stock has a market capitalization of $63.76 million, a PE ratio of -4.66 and a beta of 0.48. electroCore has a 52 week low of $4.16 and a 52 week high of $15.68.

About electroCore

(Get Free Report)

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.

Further Reading

Analyst Recommendations for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.